Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBXO7 Activators

The chemical class identified as FBXO7 Activators consists of compounds that, while not directly activating FBXO7 (F-box protein 7), are theorized to exert an indirect influence on its functional dynamics through the modulation of associated cellular pathways and processes. FBXO7, a multifunctional protein, plays a critical role in various cellular mechanisms including the ubiquitin-proteasome system, cell cycle regulation, and mitochondrial function. The compounds in this class, such as MG132, Bortezomib, and Lactacystin, primarily interact with the proteasome degradation pathway. Their role as proteasome inhibitors potentially affects the degradation processes in which FBXO7 is involved. For instance, by inhibiting the proteasome, these compounds could indirectly affect the turnover of proteins targeted by FBXO7, leading to altered cellular responses. Additionally, compounds like Carfilzomib and Velcade (Bortezomib) that selectively target proteasomal activity might create a cellular context that indirectly influences the activity of FBXO7, particularly in its role related to protein degradation.

Furthermore, this class includes compounds like Oltipraz, Metformin, and Resveratrol, which affect cellular pathways like antioxidant responses, metabolic processes, and sirtuin pathways. These compounds can indirectly influence mitochondrial functions and cellular metabolism, thereby potentially affecting FBXO7's role in these processes. For example, Metformin, known for its effects on glucose metabolism, could indirectly impact FBXO7's involvement in mitochondrial regulation. Similarly, Resveratrol, by modulating sirtuin pathways, might influence cellular processes where FBXO7 plays a role. Other compounds like Sorafenib, a kinase inhibitor, and Lithium, known for modulating Wnt signaling, represent a broader spectrum of cellular signaling modulation that can indirectly impact FBXO7's activity. Trichostatin A, as an HDAC inhibitor, could affect gene expression patterns, potentially impacting the regulatory roles of FBXO7.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor, could affect the ubiquitin-proteasome system, potentially influencing FBXO7 activity.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Another proteasome inhibitor, might impact proteasomal degradation processes involving FBXO7.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

A specific inhibitor of the proteasome, could influence FBXO7's role in protein degradation.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

A selective proteasome inhibitor, might impact the degradation pathways where FBXO7 is involved.

Oltipraz

64224-21-1sc-205777
sc-205777A
500 mg
1 g
$286.00
$622.00
(1)

A compound known for its role in antioxidant response, could influence cellular pathways related to FBXO7.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor, could affect cellular growth pathways, potentially influencing FBXO7 activity.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Known for its effects on cellular metabolism, might influence mitochondrial function and thereby FBXO7 activity.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Affects sirtuin pathways, potentially influencing pathways related to FBXO7's function in mitochondrial regulation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

A kinase inhibitor, could impact cellular signaling pathways, potentially affecting FBXO7.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Known for modulating Wnt signaling, might influence pathways related to FBXO7's function.